secwatch / observer
8-K filed November 7, 2023, 6:59 PM ET ticker OM CIK 0001484612
earnings confidence high sentiment neutral materiality 0.50

Outset Medical Q3 revenue $30.4M (+9% YoY); net loss $46.2M; reiterates FY23 guidance ~$130M

Outset Medical, Inc.

2023-Q3 EPS reported -$2.72 revenue$99,869,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Outset Medical, Inc. reported third quarter ended September 30, 2023 results: revenue Revenue for the third quarter was $30.4 million, net income Net loss was ($46.2) million, EPS ($0.93) per share. Guidance reaffirmed.

Period
third quarter ended September 30, 2023
Revenue
Revenue for the third quarter was $30.4 million
Net income
Net loss was ($46.2) million
EPS
($0.93) per share
Guidance
reaffirmed
Result
reported results
Exact text from the filing
technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2023. Revenue for the third quarter was $30.4 million, a 9% increase over revenue of $27.8 million in the third quarter of 2022, and gross margin was 23.6%, or 25.6% on a non-GAAP basis, compared to 16.4% on a non-GAAP basis in the
View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Outset Medical, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-060250
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.